Bostal Drug Delivery

Bostal Drug Delivery is a biotechnology and pharmaceutical startup that focuses on developing advanced drug preparation products tailored for innovative drug delivery systems. Established in 2013 and based in Guangzhou, Guangdong, the company specializes in creating technology platforms to facilitate the development of new drugs, enhance existing drugs, and create premium generic medications. With the slogan "Innovative drug delivery solutions enhancing the development and improvement of pharmaceuticals since 2013," Bostal Drug Delivery has attracted significant attention in the biotechnology and healthcare industries. The latest milestone for the company is its Series B investment which took place on 21 August 2023. This investment round saw the participation of a diverse group of investors including October Capital, 万联证券股份有限公司, BOC & Utrust Private Equity Fund Management, YIMI, Wanlian Guangsheng, Guangzhou Karma Investment, Chuangyu Investment Management, Guangdong Technology Financial Group, Panyu Industry Investment, Knowledge City Venture Capital. This injection of funds is expected to propel Bostal Drug Delivery's efforts in revolutionizing drug delivery and pharmaceutical preparation technology.